secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K/A
Filed at:   2021-09-27T23:59:59+00:00
Accession:  0001193125-21-282945
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences corrects FVC data error for patient five in IGNITE DMD trial; mean improvement +8.5%
--------------------------------------------------------------------------------

- Corrected 1.5-year FVC change for patient five: +22.5% (previously reported incorrectly).
- Mean percent predicted FVC improvement for patients 4-6: +8.5% (range +0.6% to +22.5%).
- Mean difference vs natural history decline of 7.5% was +16.0% over 1.5 years.
- All three patients treated with 2E14 vg/kg SGT-001 show stability or improvement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312521282945/0001193125-21-282945-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312521282945/d231696d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-282945

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer